08/08
Headlines

GILD

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Jason Knox02 mins

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 1.14% to $8.65. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -2.87% in last session and finished the day at $8.13. Traded volume was…

Read More

Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Kristen Barton02 mins

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session…

Read More

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Kevin Long02 mins

ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -3.34% in last session and finished the day at $8.69. Traded volume was 1,200.00 shares in the last session and the average volume of the stock remained 26.48 million shares….

Read More

Ever Green Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Delta Air Lines (NYSE:DAL), Central Garden & Pet Company (NASDAQ:CENT), Safeway (NYSE:SWY), Nomura (NYSE:NMR)

Jayne Crisman03 mins

Strides Arcolab, announced that it has entered into a licensing agreement with Gilead Sciences Inc. (NASDAQ:GILD)under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin…

Read More

Ever Green Stocks: The Charles Schwab Corporation (NYSE:SCHW), Gilead Sciences Inc. (NASDAQ:GILD), NextEra Energy Partners, LP (NYSE:NEP), Teleflex (NYSE:TFX), Fuel-Tech (NASDAQ:FTEK)

Kevin Long02 mins

The PGA Tour and The Charles Schwab Corporation (NYSE:SCHW) have reached an agreement to extend the sponsorship of the Champions Tour’s season-long points race and season-ending tournament for 20 years — the longest marketing agreement the Tour has ever signed with a sponsor. The Charles Schwab Corporation (NYSE:SCHW) belongs to Financial sector. Its net profit…

Read More

Watch 5 Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Helmerich & Payne, Inc. (NYSE:HP), eBay Inc. (NASDAQ:EBAY), Coach, Inc. (NYSE:COH), Penford Corporation (NASDAQ:PENX)

John Bellich02 mins

On Dec. 15, Gilead Sciences Inc. (NASDAQ:GILD) announced that Philippe C. Bishop, MD, will join the company as Senior Vice President, Hematology and Oncology Therapeutics. In this position, Dr. Bishop will report to John McHutchison, MD, Executive Vice President, Clinical Research and will have responsibility for Gilead’s programs in oncology. Dr. Bishop will also join…

Read More